Jun 02, 2020
WAKIX® (pitolisant) Data From Harmony Biosciences Included on American Academy of Neurology Science Highlights Virtual Platform
May 13, 2020
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2020
May 07, 2020
Sosei Heptares Announces Further Scientific Progress with Orexin Agonist Program in Conjunction With Spin-off Companies Orexia and Inexia
Apr 27, 2020
Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients
Mar 30, 2020
Harmony Biosciences Highlights Publication Of Narcolepsy Treatment Scientific Review In Sleep Medicine
Mar 25, 2020
Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
Jan 13, 2020
Sosei Heptares: Significant Progress by Orexia and Inexia With Orexin Agonist Program Triggers Next Tranche of Funding From Medicxi
Dec 10, 2019
Eisai Presents New Analyses of Potential Blood-Based Alzheimer's Diagnostic Test and Lemborexant as Potential Sleep-Wake Disorder Therapy
Oct 24, 2019
World first clinical trial commenced in alcohol use disorder
Sep 20, 2019
Harmony Biosciences Announces Recipients of 2019 Patients at the Heart Grant in Recognition of World Narcolepsy Day
Jun 04, 2019
Harmony Biosciences To Present New Data On Pitolisant In Patients With Narcolepsy At SLEEP 2019 Meeting
Apr 29, 2019
Harmony Biosciences To Present Data On Pitolisant In Patients With Narcolepsy At 2019 American Academy Of Neurology Meeting
Mar 11, 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Feb 04, 2019
Sosei Heptares Announces Medicxi to Invest Up To EUR40 Million in New Collaboration Based on its Orexin Agonist Program
Jan 15, 2019
New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
Dec 05, 2018
Harmony Biosciences Wins Four Industry Awards For Know Narcolepsy® Educational Campaign
Oct 17, 2018
Eisai and Purdue Pharma Announce Positive Topline Results of SUNRISE 2, the Second Phase 3 Pivotal Study of Lemborexant
Oct 09, 2018
New Survey Identifies Need For Increased Education About And New Treatment Options For Narcolepsy
Sep 27, 2018
Data On Abuse Potential Of Pitolisant Presented At 2018 European Sleep (ESRS) Congress
Sep 05, 2018
Harmony Biosciences To Present Data On Its Investigational Product, Pitolisant, At Upcoming International Narcolepsy Symposium